Advanced filters
News
You can read the statement in full here.
The statement sets out considerations for patients (and/…
News
NICE, NHS England and NHS Improvement have taken advice from clinical experts to review the…
Press release
Muscular Dystrophy UK has responded to new guidelines from the British Medical Association (BMA) on…
News
The treatment, which has been developed by AveXis, is recommended by the agency's Committee for…
News
On 25 March these measures became law in the form of the Coronavirus Act 2020.
Impact on social…
News
Muscular Dystrophy UK has written an open letter to NICE responding to its guidance on critical…
Your story
Through this agreement, people with SMA types 1, 2 and 3 can now access the treatment, although…
News
The money will be used to match-fund the costs of installing Changing Places toilets in existing…
News
This year, the Scottish Medicines Consortium (SMC) has assessed mexiletine hydrochloride (also…
News
AveXis started to roll out this programme in January 2020 for children age under 2 years who have…